Author's posts
Editorial: The transparency trap
Among all the proffered panaceas for reducing America’s high healthcare costs, price transparency is the least likely to make a major dent in the problem.
Can a doctor’s medical necessity decision be a false claim?
The underlying case centers on whether a False Claims Act case can be based on the allegation that a physician’s determination of medical necessity is false. Courts around the country have ruled differently on that issue.
Q&A: Centene CEO Michael Neidorff stays focused on attaining growth
Centene Corp. CEO Michael Neidorff says that the large Medicaid managed-care plan is well positioned to deliver high quality products that lower costs.
Breaking Bias: Everyone benefits from growing diversity in healthcare leadership
In this era of consumer-centric care, it’s critically important to ensure that our clinicians, executives and even members of our governing boards, accurately represent and reflect the communities we serve.
IT leaders looking for meaningful data-exchange regs
Industry stakeholders were generally optimistic about proposed data-exchange rules, but they want regulators to ensure the information is useful to patients 
and clinicians.
CIOs focus on proving IT’s usefulness to drive adoption
After spending billions of dollars on new technology solutions, healthcare leaders must figure out ways to ensure a solid return investment. Children’s Health CIO Pamela Arora and Centura Health CIO Ken Lee explain their IT strategies for driving…
Week Ahead: CVS, CHS, AllScripts ready earnings reports
Insurance industry analysts are anxiously waiting for CVS Health to report its Q4 2018 financial results. It’ll be the first quarter since the pharmacy behemoth closed its $70 billion deal to acquire health insurer Aetna in November.
New Justice Dept. policies, new AG may mute False Claims Act whistleblowers
Healthcare industry groups have new hope that whistleblower cases will dwindle or even go away under new Attorney General William Barr.
Name and shame: HHS using disclosure, transparency to try to force change
HHS is using a public approach to enforcing its rules on healthcare stakeholders.
Gilead accused of funneling kickbacks to providers to boost sales
Gilead Sciences is accused of giving kickbacks to healthcare organizations, government agencies, universities and community groups to boost sales of its hepatitis and HIV drugs, resulting in billions of dollars in excess government spending.
